This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ucb Pharma, S.a.. Active years: 2008-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2014
Title: Innovator Spotlight: Heather Margaret Ladyman
Introduction: Heather Margaret Ladyman, located in Slough, GB, is an accomplished inventor with a notable portfolio of three patents to her name. Her innovative work in the field of biological products, particularly in relation to antibody molecules, has significantly contributed to the advancement of medical science.
Latest Patents: Among her latest patents are groundbreaking antibody molecules that incorporate at least one complementarity-determining region (CDR) derived from a mouse monoclonal antibody with specificity for human CD22. These patents detail a CDR grafted antibody featuring modified CDRs, along with the corresponding DNA sequences that encode the chains of these antibody molecules. Additionally, the patents discuss the vectors, transformed host cells, and various applications of these antibody molecules in the treatment of diseases mediated by cells that express CD22.
Career Highlights: Heather is currently employed at UCB Pharma, a leading global biopharmaceutical company that emphasizes the research and development of innovative medical therapies. Her work at UCB Pharma not only showcases her expertise in biomedicine but also her commitment to addressing complex health issues through innovative solutions.
Collaborations: Heather has collaborated with esteemed colleagues such as Simon Peter Tickle and Andrew George Popplewell, fostering a collaborative environment that promotes advancements in their shared field of expertise. Their collective efforts in research and development highlight the importance of teamwork in driving innovation.
Conclusion: Heather Margaret Ladyman's innovative contributions to the field of biological products demonstrate her dedication to improving healthcare through her inventive spirit. With her strong background and ongoing work at UCB Pharma, she continues to pave the way for new treatments that address critical medical challenges. Her accomplishments serve as an inspiration for aspiring inventors and researchers in the biotechnology sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile